Table 6.
Participants | Study Design | Article | |
---|---|---|---|
Biomarker of: | |||
↗ severity of CUD: ↘ leptin plasmatic levels | N = 40 | Cross-sectional | Escobar et al., 2018 [71] |
↗ withdrawal symptoms: ↗ plasmatic adipokine levels | N = 104 | Cross-sectional | Levandowski et al., 2013 [72] |
↘ abstinence: ↗ prolactin plasmatic levels | N = 86 | Prospective | Patkar et al., 2002 [73] |
↘: decreased, ↗: increased.